SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Hester Biosciences - Quaterly Results

10 May 2024 Evaluate
The revenue for the March 2024 quarter is pegged at Rs. 728.72 millions, about 20.06% up against Rs. 606.96 millions recorded during the year-ago period.Modest increase of 18.65% in the Net Profit was reported from. 62.63 millions to Rs. 74.31  millions.Operating Profit saw a handsome growth to 136.18 millions from 118.69 millions in the quarter ended March 2024.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202403 202303 % Var 202403 202303 % Var 202403 202303 % Var
Sales 728.72 606.96 20.06 2851.55 2540.00 12.27 2851.55 2540.00 12.27
Other Income 12.03 9.50 26.63 42.62 53.23 -19.93 42.62 53.23 -19.93
PBIDT 136.18 118.69 14.74 516.03 602.09 -14.29 516.03 602.09 -14.29
Interest 13.10 3.48 276.44 50.93 64.97 -21.61 50.93 64.97 -21.61
PBDT 123.08 115.21 6.83 465.10 537.12 -13.41 465.10 537.12 -13.41
Depreciation 20.83 26.21 -20.53 97.78 97.88 -0.10 97.78 97.88 -0.10
PBT 102.25 89.00 14.89 367.32 439.24 -16.37 367.32 439.24 -16.37
TAX 27.94 26.37 5.95 95.73 115.82 -17.35 95.73 115.82 -17.35
Deferred Tax -4.82 3.47 -238.90 -0.62 8.55 -107.25 -0.62 8.55 -107.25
PAT 74.31 62.63 18.65 271.59 323.42 -16.03 271.59 323.42 -16.03
Equity 85.07 85.07 0.00 85.07 85.07 0.00 85.07 85.07 0.00
PBIDTM(%) 18.69 19.55 -4.43 18.10 23.70 -23.66 18.10 23.70 -23.66

Hester Biosciences Share Price

1492.80 20.80 (1.41%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×